Resmed (ASX:RMD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Resmed (ASX:RMD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Statement of changes in beneficial ownership
Statement of CDIs on issue - RMD
Statement of changes in beneficial ownership
Accelerated Share Repurchase Agreement Announcement
LR 1.15.3 Compliance
Update - Dividend/Distribution - RMD
ResMed updates FX rate for upcoming dividend to ASX CDI holders
Details of Auditor Appointment/Resignation
Resmed Form 10-K Annual Report
ResMed reports 10% revenue growth in FY2026, acquires Noctrix, plans MatrixCare sale
Statement of changes in beneficial ownership
Deferral of Conversions between Australian and US Registers
ResMed defers stock register conversions around 20 August 2026 dividend record date
Dividend/Distribution - RMD
ResMed declares USD 0.066 quarterly dividend for August 2026 payment
Resmed Announces Results for the Fourth Quarter of FY2026
Resmed reports strong FY2026 results with 10% revenue growth and 17% EPS increase, raises dividend by 10%
144 Report of proposed sale of securities
Statement of CDIs on issue - RMD
Statement of changes in beneficial ownership
Resmed Announces Agreement to Sell MatrixCare Business
ResMed to sell MatrixCare business for $490 million to focus on sleep and connected care markets
Statement of CDIs on issue - RMD
Resmed to Report Fourth Quarter Fiscal 2026 Results